Salvianolic Acid B Inhibits Hand-Foot-Mouth Disease Enterovirus 71 Replication through Enhancement of AKT Signaling Pathway

다국어 초록 (Multilingual Abstract)

Hand, foot, and mouth disease (HFMD) is caused by enterovirus 71 (EV71) in infants and children under six years of age. HFMD is characterized by fever, mouth ulcers, and vesicular rashes on the palms and feet. EV71 also causes severe neurological manifestations, such as brainstem encephalitis and aseptic meningitis. Recently, frequent outbreaks of EV71 have occurred in the Asia-Pacific region, but currently, no effective antiviral drugs have been developed to treat the disease. In this study, we investigated the antiviral effect of salvianolic acid B (SalB) on EV71. SalB is a major component of the Salvia miltiorrhiza root and has been shown to be an effective treatment for subarachnoid hemorrhages and myocardial infarctions.
HeLa cells were cultured in 12-well plates and treated with SalB (100 or 10 μg/ml) and 106 PFU/ml of EV71. SalB treatment (100 μg/ml) significantly decreased the cleavage of the eukaryotic eIF4G1 protein and reduced the expression of the EV71 capsid protein VP1. In addition, SalB treatment showed a dramatic decrease in viral infection, measured by immunofluorescence staining. The Akt signaling pathway, a key component of cell survival and proliferation, was significantly increased in EV71-infected HeLa cells treated with 100 μg/ml SalB. RT-PCR results showed that the mRNA for anti-apoptotic protein Bcl-2 and the cell cycle regulator Cyclin-D1 were significantly increased by SalB treatment. These results indicate that SalB activates Akt/PKB signaling and inhibits apoptosis in infected HeLa cells. Taken together, these results suggest that SalB could be used to develop a new therapeutic drug for EV71-induced HFMD.

참고문헌 (Reference)

1 Solomon T, "Virology, epidemiology, pathogenesis, and control of enterovirus 71" 10 : 778-790, 2010

2 Lim BK, "Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model" 199 : 1-8, 2015

3 Chen YH, "Salvianolic acid B protects brain against injuries caused by ischemia-reperfusion in rats" 21 : 463-466, 2000

4 Wang QQ, "Salvianolic acid B inhibits the development of diabetic peripheral neuropathy by suppressing autophagy and apoptosis" 71 : 417-428, 2019

5 Chen YH, "Salvianolic acid B attenuates VCAM-1 and ICAM-1expression in TNF-alpha-treated human aortic endothelial cells" 82 : 512-521, 2001

6 Tan CW, "Recent developments in antiviral agents against enterovirus 71infection" 21 : 14-, 2014

7 Esfandiarei M, "Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent" 78 : 4289-4298, 2004

8 Hyoung Jae Lee, "Large Scale Isolation and Purification of Salvianolic Acid B in High Purity from Roots of Dansham (Salvia miltiorrhiza Bunge)" 한국식품과학회 19 (19): 497-502, 2010

9 Lin YL, "In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells" 105 : 215-222, 2006

10 이윤경, "Fructus Amomi Cardamomi Extract Inhibits Coxsackievirus-B3 Induced Myocarditis in a Murine Myocarditis Model" 한국미생물·생명공학회 26 (26): 2012-2018, 2016

11 Castello A, "Differential cleavage of eIF4GI and eIF4GII in mammalian cells" 281 : 33206-33216, 2006

12 Plevka P, "Crystal structure of human enterovirus 71" 336 : 1274-, 2012

13 Liu P, "Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B" 8 : 679-685, 2002

14 Ooi MH, "Clinical features, diagnosis, and management of enterovirus 71" 9 : 1097-1105, 2010

15 한재영, "Cholic Acid Attenuates ER Stress-Induced Cell Death in Coxsackievirus- B3 Infection" 한국미생물·생명공학회 28 (28): 109-114, 2018

16 Zhao GR, "Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B" 46 : 73-81, 2008